Reuters logo
5 个月前
BRIEF-Eiger Biopharmaceuticals Q4 loss per share $1.53
2017年3月23日 / 下午12点49分 / 5 个月前

BRIEF-Eiger Biopharmaceuticals Q4 loss per share $1.53

March 23 (Reuters) - Eiger Biopharmaceuticals Inc:

* Eiger biopharmaceuticals reports fourth quarter and full year 2016 financial results

* Q4 loss per share $1.53

* Q4 earnings per share view $-1.36 -- Thomson Reuters I/B/E/S

* Eiger Biopharmaceuticals Inc- as of Dec 31, 2016, eiger had cash, cash equivalents and short term marketable securities of $59.9 million, compared to $4.8 million at December 31, 2015 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below